Cancer Treatment and Prevention Center hosts representatives from one of Israel’s largest hospitals
Thursday, September 13, 2012
Above, UTHSCT staff, representatives of the Tel Aviv Sourasky Medical Center, and Varian Medical Systems project managers pose for a photo in the Cancer Treatment and Prevention Center. Shown are (from left) Karen Meshell, nurse manager of the oncology clinic; Dr. Ravit Geva, medical oncologist, and Gadi Paster-Bachar, IT specialist, from the Tel Aviv Sourasky Medical Center; and Varian project managers Moshe Steiner, Israel; Ken Hotz, Winnipeg, Manitoba, Canada; and David Rose, Crawley, England; Cody Boyd, director of oncology services; and Tony Primrose, Varian project manager, Dallas.
Two representatives from the third-largest hospital in Israel visited the new Cancer Treatment and Prevention Center at The University of Texas Health Science Center at Tyler this week.
Dr. Ravit Geva, a medical oncologist, and Gadi Paster-Bachar, an information technology specialist, work at one of the foremost health-care facilities in Israel, the Tel Aviv Sourasky Medical Center. The facility has 1,300 hospital beds and 170 outpatient clinics.
Dr. Geva and Paster-Bachar came almost 7,000 miles – from the other side of the world – to Tyler to examine UTHSCT’s Varian TrueBeam Linear Accelerator and the systems that support it. UTHSCT’s cancer center is a site of excellence for Varian Medical Systems, manufacturer of the TrueBeam.
The Varian TrueBeam, shown at left with Dr. Geva and Paster-Bachar, and its advanced software systems deliver fast, powerful, precise, and accurate radiation therapy that targets cancer cells while minimizing healthy tissue’s exposure to radiation.
Accompanying Dr. Geva and Paster-Bachar is Moshe Steiner, an engineer and a Varian project manager in Israel. The group spent three days – from Monday, Sept. 10, through Wednesday, Sept. 12 – checking out UTHSCT’s Varian system.
For more than 60 years, The University of Texas Health Science Center at Tyler has provided excellent patient care and cutting-edge treatment, specializing in pulmonary disease, cancer, heart disease, primary care, and the disciplines that support them. UTHSCT’s annual operating budget of $125 million represents a major economic impact of over $287 million for the Northeast Texas region. Since 2002, scientists in the Center for Biomedical Research have been awarded more than $120 million in research dollars. As the academic health science center for Northeast Texas, its graduate medical education programs – with residencies in family medicine and occupational medicine – provide doctors for many communities throughout the region and beyond. UTHSCT is also the program sponsor of the residency program in internal medicine at Good Shepherd Medical Center in Longview.